Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 07, 2021

BUY
$1.62 - $3.05 $24,300 - $45,750
15,000 New
15,000 $31,000
Q4 2020

Feb 10, 2021

SELL
$1.44 - $1.98 $65,478 - $90,032
-45,471 Closed
0 $0
Q4 2019

Feb 07, 2020

SELL
$1.23 - $2.67 $8,448 - $18,340
-6,869 Reduced 13.12%
45,471 $72,000
Q3 2019

Oct 28, 2019

BUY
$1.25 - $5.0 $8,586 - $34,345
6,869 Added 15.11%
52,340 $115,000
Q2 2019

Aug 05, 2019

BUY
$1.65 - $6.72 $24,750 - $100,800
15,000 Added 49.23%
45,471 $91,000
Q1 2019

Apr 26, 2019

BUY
$4.84 - $9.07 $48,400 - $90,700
10,000 Added 48.85%
30,471 $213,000
Q4 2018

Feb 08, 2019

BUY
$4.21 - $14.28 $86,182 - $292,325
20,471 New
20,471 $128,000

Others Institutions Holding ECOR

About electroCore, Inc.


  • Ticker ECOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 71,176,896
  • Market Cap $445M
  • Description
  • electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....
More about ECOR
Track This Portfolio

Track Brighton Jones LLC Portfolio

Follow Brighton Jones LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brighton Jones LLC with notifications on news.